These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23289804)

  • 1. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
    Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
    Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
    Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
    Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
    Russo PD; Damante G; Pasca S; Turello M; Barillari G
    Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
    Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
    Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
    Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
    Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
    Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women.
    Chatzidimitriou M; Chatzidimitriou D; Mavridou M; Anetakis C; Chatzopoulou F; Lialiaris T; Mitka S
    Int J Lab Hematol; 2017 Dec; 39(6):590-595. PubMed ID: 28603947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.
    Mrad M; Wathek C; Saleh MB; Baatour M; Rannen R; Lamine K; Gabsi S; Gritli N; Fekih-Mrissa N
    Transfus Apher Sci; 2014 Apr; 50(2):283-7. PubMed ID: 24440586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
    Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
    Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
    Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
    McGimpsey SJ; Woodside JV; Cardwell C; Cahill M; Chakravarthy U
    Ophthalmology; 2009 Sep; 116(9):1778-1787.e1. PubMed ID: 19729099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilioretinal artery: Vasculogenesis might be promoted by plasminogen activator inhibitor-1 5G allele.
    Yilmaz S; Ardagil A; Akalin I; Altinel MG; Dag Y; Kurum E; Koyun E; Ari Yaylali S; Bayramlar H
    Ophthalmic Genet; 2017; 38(5):428-433. PubMed ID: 28145780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.